The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice.

MLA

Thomsen, Lucy R., et al. “The Impact of Piperazine and Antipsychotic Co-Exposures and CB1 Blockade on the Effects Elicited by AMB-FUBINACA, a Synthetic Cannabinoid, in Mice.” European Journal of Pharmacology, vol. 979, Sept. 2024, p. 176844. EBSCOhost, https://doi.org/10.1016/j.ejphar.2024.176844.

APA

Thomsen, L. R., Glass, M., & Rosengren, R. J. (2024). The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice. European Journal of Pharmacology, 979, 176844. https://doi.org/10.1016/j.ejphar.2024.176844

Chicago

Thomsen, Lucy R, Michelle Glass, and Rhonda J Rosengren. 2024. “The Impact of Piperazine and Antipsychotic Co-Exposures and CB1 Blockade on the Effects Elicited by AMB-FUBINACA, a Synthetic Cannabinoid, in Mice.” European Journal of Pharmacology 979 (September): 176844. doi:10.1016/j.ejphar.2024.176844.